DK0385909T3 - Kit eller middel til forebyggelse eller behandling af HIV-1-infektioner - Google Patents

Kit eller middel til forebyggelse eller behandling af HIV-1-infektioner

Info

Publication number
DK0385909T3
DK0385909T3 DK90610014.4T DK90610014T DK0385909T3 DK 0385909 T3 DK0385909 T3 DK 0385909T3 DK 90610014 T DK90610014 T DK 90610014T DK 0385909 T3 DK0385909 T3 DK 0385909T3
Authority
DK
Denmark
Prior art keywords
hiv
infections
prevention
treatment
remedy
Prior art date
Application number
DK90610014.4T
Other languages
English (en)
Inventor
Franklin Volvovitz
Original Assignee
Microgenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microgenesys Inc filed Critical Microgenesys Inc
Application granted granted Critical
Publication of DK0385909T3 publication Critical patent/DK0385909T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK90610014.4T 1989-03-03 1990-03-01 Kit eller middel til forebyggelse eller behandling af HIV-1-infektioner DK0385909T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31827289A 1989-03-03 1989-03-03

Publications (1)

Publication Number Publication Date
DK0385909T3 true DK0385909T3 (da) 1994-08-15

Family

ID=23237447

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90610014.4T DK0385909T3 (da) 1989-03-03 1990-03-01 Kit eller middel til forebyggelse eller behandling af HIV-1-infektioner

Country Status (8)

Country Link
EP (1) EP0385909B1 (da)
JP (1) JPH03163027A (da)
AT (1) ATE108335T1 (da)
AU (1) AU635001B2 (da)
CA (1) CA2011299A1 (da)
DE (1) DE69010523D1 (da)
DK (1) DK0385909T3 (da)
IL (1) IL93599A0 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456924A (en) * 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
WO1991002743A1 (en) * 1989-08-23 1991-03-07 The General Hospital Corporation Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof
US5234905A (en) * 1991-02-22 1993-08-10 University Of Colorado Foundation, Inc. Soluble CD4 molecules modified to prolong circulating half-life
ATE170559T1 (de) * 1991-05-31 1998-09-15 Genentech Inc Behandlung der hiv-assoziierten immun- thrombopenie purpura
JPH08510246A (ja) * 1993-05-07 1996-10-29 アクゾ・ノベル・エヌ・ベー Ｈｉｖ免疫原性複合体
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
CA3063037A1 (en) * 2017-05-10 2018-11-15 Albajuna Therapeutics, S.L. Fc-fusion protein derivatives with high dual hiv antiviral and immunomodulatory activity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US344304A (en) * 1886-06-22 Spindle-support
FR2606029B2 (fr) * 1986-04-08 1989-02-03 Transgene Sa Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
IL84154A0 (en) * 1986-10-16 1988-03-31 Microgenesys Inc Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same
EP0272858A3 (en) * 1986-12-15 1989-07-12 Repligen Corporation Recombinant hiv envelope proteins produced in insect cells
AU609447B2 (en) * 1987-02-19 1991-05-02 Nissin Shokuhin Kabushiki Kaisha Methods and materials for hiv detection and therapy
NZ223980A (en) * 1987-03-23 1991-02-26 Hiver Ltd An aids-type virus vaccine comprising an antibody equivalent which recognises an epitope on a cd4 cell-marker
WO1988007376A1 (en) * 1987-03-27 1988-10-06 Hiroshi Okajima Remedy for viral diseases
JPS6463394A (en) * 1987-09-04 1989-03-09 Kyowa Hakko Kogyo Kk Novel chimera polypeptide

Also Published As

Publication number Publication date
IL93599A0 (en) 1990-12-23
JPH03163027A (ja) 1991-07-15
EP0385909A3 (en) 1991-04-10
CA2011299A1 (en) 1990-09-03
AU635001B2 (en) 1993-03-11
ATE108335T1 (de) 1994-07-15
DE69010523D1 (de) 1994-08-18
AU5061090A (en) 1990-11-01
EP0385909B1 (en) 1994-07-13
EP0385909A2 (en) 1990-09-05

Similar Documents

Publication Publication Date Title
DK0428038T3 (da) Transdermal administration af 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
FI924553A (fi) Tiofensulfonamider anvaendbara som kolanhydrasinhibitorer
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
DK0563093T4 (da) Præparat anvendt som terapeutisk middel mod kroniske virale hepatitissygdomme
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
ATE139531T1 (de) Arylsubstituierte rhodaninderivate
DK422589D0 (da) Farmaceutisk praeparat til behandling af immundefekttilstande
DE58909850D1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
DK0385909T3 (da) Kit eller middel til forebyggelse eller behandling af HIV-1-infektioner
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
EP0261524A3 (de) Arzneimittelzubereitungen
NO883986D0 (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
ATE80553T1 (de) Behandlung von viraler infektion.
DK0490383T3 (da) Peptider af HIV-gag-proteinet, fremstilling og anvendelse deraf
DK630088D0 (da) Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
DK0579765T3 (da) Fremgangsmåde og præparat til behandling af herpes-relaterede sygdomme
NO901892L (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
ES2043896T3 (es) Procedimiento para la preparacion de derivados de tetrahidropiridina.
EP0392666A3 (en) Anti-HIV compositions
NO903705D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n-disubstituerte arylcykloalkylaminer.
DK363985A (da) Antineoplastisk middel